Quick Takeaways: Why It Matters? Antech’s peer-reviewed Accuplex findings could strengthen its competitive position in canine vector-borne disease diagnostics, particularly for Ehrlichia antibody detection, where it outperformed IDEXX’s SNAP 4Dx Plus in this study. Independent ...
Quick Takeaways: Why It Matters? Capillus’ launch of the Pet Vest and Pet Joint Wrap extends its human red‑light therapy platform into the fast‑growing pet wellness segment, offering non‑invasive, at‑home photobiomodulation for mobility, comfort and recovery. With prices ...
Quick Takeaways: Why It Matters? Loyal’s completion of the RXE efficacy requirement for LOY‑003 means all three of its canine longevity candidates (LOY‑001, LOY‑002, LOY‑003) have now met the FDA’s efficacy bar under the Expanded Conditional Approval pathway, putting the compan...
Cover Story Featured Article Product Launch Product Showcase Nestlé Invests CHF 157M to Expand Purina Pet Food Production Nestlé is investing more than CHF 157 million to expand its Purina pet food manufacturing site in Rayong, Thailand, increasing production capacity for pet food and trea...
Quick Takeaways: Why It Matters? Cronus Pharma’s launch of Robenacoxib Injection gives US veterinarians the first FDA‑approved bioequivalent to Onsior (robenacoxib) Injection, providing a cost‑effective, short‑term NSAID option for postoperative pain an...
Quick Takeaways: Why It Matters? The FDA’s Emergency Use Authorization for Simparica Trio to treat New World screwworm (NWS) larvae in dogs gives veterinarians a convenient, oral option that can be used alongside existing livestock tools (e.g., Dectomax...
Quick Takeaways: Why It Matters? IDEXX’s Catalyst proBNP brings a well‑known heart‑disease blood test into the vet clinic with results in minutes, so vets can spot hidden heart problems, decide quickly in breathing emergencies, and monitor patients without waiting day...
Quick Takeaways: Why It Matters? If the science holds up, this could open a future premium category for hypoallergenic dogs and related breeding or licensing programs, creating new value in the pet biotech space while also raising major regulatory, ethical, and animal-welfare h...
Quick Takeaways: Why It Matters? The deal broadens PetIQ’s product mix into a higher-value mobility category that can be cross-sold through retail, e-commerce and distribution channels, potentially increasing average basket size and strengthening PetIQ’s positioning as a branded pet health...
Quick Takeaways: Why It Matters? By terminating the PrecisePRP arrangement with VetStem, PetVivo removes outstanding invoices, royalties and milestone overhangs from a non-core product line, which should simplify the story for investors and management while freeing attention and capital fo...
